ScreenerHero

CLDI Calidi Biotherapeutics, Inc.

AMEX · US · Healthcare · Biotechnology · calidibio.com
1.040USD+2.97%Mkt Cap: 3.82M $P/E: —

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatm…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.47BUSDP/E 29.3
MRNA
Moderna, Inc.
$78.65BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.14BUSDP/E 18.3
ARGX
argenx SE
$51.48BUSDP/E 31.2
ARGX
argenx SE
$48.23BUSDP/E 31.4
UCB
UCB SA
$41.82BUSDP/E 17.8
RVMD
Revolution Medicines, Inc.
$40.32BUSD
ONC
BeOne Medicines AG
$39.83BUSDP/E 62.6
RPRX
Royalty Pharma plc
$32.48BUSDP/E 29.9
ALNY
Alnylam Pharmaceuticals, Inc.
$30.04BUSDP/E 37.9
ROIV
Roivant Sciences Ltd.
$24.71BUSD
BNTX
BioNTech SE
$23.13BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
GMAB
Genmab A/S
$22.17BUSDP/E 28.4
INSM
Insmed Incorporated
$21.94BUSD
GMAB
Genmab A/S
$21.10BUSDP/E 29.1
ASND
Ascendis Pharma A/S
$14.65BUSDP/E 17.1
EXEL
Exelixis, Inc.
$14.62BUSDP/E 18.6
JAZZ
Jazz Pharmaceuticals plc
$14.44BUSDP/E 15.2
SMMT
Summit Therapeutics Inc.
$13.70BUSD

Key Statistics

Company
Market Cap3.82M USD
Enterprise Value516.43K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.91M USD
Revenue/Share—
Last Price1.040 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.13
PEG—
EV/EBITDA-0.03
EV/Revenue—
P/S—
P/B0.68
EPS (TTM)-36.47
EPS (Forward)-0.90
52W Range
0.98600% of range27.84
52W High27.84 USD
52W Low0.9860 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-529.56%
ROA-224.75%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.29M USD
CapEx (TTM)120.00K USD
FCF Margin—
FCF Yield-261.98%
Net Debt-2.13M USD
Net Debt/EBITDA0.13
Balance Sheet
Debt/Equity0.68
Current Ratio1.68
Quick Ratio1.34
Book Value/Sh1.50 USD
Cash/Share1.57 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:16
Split DateJul 31, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.68M
Float2.57M
Insiders0.61%
Institutions1.00%
Short Interest
Short Ratio3.3d
Short % Float8.88%
Short % Out.8.81%
Shares Short227.78K
Short (prev mo.)313.26K
Technical
SMA 501.364 (-23.8%)
SMA 2006.196 (-83.2%)
Beta1.33
S&P 52W Chg16.45%
Avg Vol (30d)191.09K
Avg Vol (10d)395.84K
Technical Indicators
RSI (14)32.2
MACD-0.1504
MACD Signal-0.1682
MACD Hist.+0.0178
BB Upper1.369 USD
BB Middle1.143 USD
BB Lower0.9176 USD
BB Width39.52%
ATR (14)0.0953 USD
Vol Ratio (20d)0.09x